Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 70 Results

Title
Intervention Indication Therapeutic Area Year Actions
Pembrolizumab adjuvant for urothelial carcinoma and/or localised muscle invasive bladder cancer Pembrolizumab (Keytruda; MK-3475) Urothelial cancer Urological Cancer 2024 View  |  Download
Pegcetacoplan for treating C3 glomerulopathy or immune-complex membranoproliferative glomerulonephritis Pegcetacoplan (APL-2) C3 glomerulopathy , Immune-complex membranoproliferative glomerulonephritis Immunology , Nephrology 2024 View  |  Download
Patritumab deruxtecan for previously treated metastatic or locally advanced EGFR mutated non-small-cell lung cancer Patritumab deruxtecan Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2024 View  |  Download
Osmertinib neoadjuvant for treating EGFR mutation positive resectable non-squamous non- small cell lung cancer Osimertinib (Tagrisso; AZD9291; osimertinib mesylate) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2024 View  |  Download
Olezarsen for treating familial chylomicronaemia syndrome Olezarsen (ISIS 678354; AKCEA-APOCIII-LRx) Familial chylomicronaemia syndrome (FCS) Endocrine Nutritional and Metabolic Disorders , Genetic Disorders 2024 View  |  Download
Odevixibat for treating biliary atresia in children following Kasai hepatoportoenterostomy Odevixibat (A4250) Biliary atresia Hepatology 2024 View  |  Download
Nivolumab-relatlimab adjuvant therapy for stage III-IV resected melanoma Nivolumab-relatlimab Melanoma Skin Cancer 2024 View  |  Download
Nivolumab for treating advanced clear cell renal cell carcinoma after systemic treatment Nivolumab (Opdivo; BMS-936558; ONO-4538) Renal cell carcinoma (RCC) Renal Cancer 2024 View  |  Download
Nirogacestat for treating desmoid tumours Nirogacestat (PF-3084014;Ogsiveo) Desmoid Tumour Musculoskeletal System 2024 View  |  Download
Niraparib with abiraterone acetate and prednisone for treating homologous recombination repair-mutated metastatic castration-sensitive prostate cancer Abiraterone acetate (Zytiga; Yonsa) , Niraparib (Zejula; MK 4827; JNJ 64091742; GSK 3985771; niraparib tosylate monohydrate) , Prednisone (Decadron; Lodotra) Prostate cancer Male Reproductive Cancer 2024 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications